Department of Bioengineering and iBB-Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.
The Discoveries Centre for Regenerative and Precision Medicine, Lisbon Campus, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.
Biotechnol J. 2018 Feb;13(2). doi: 10.1002/biot.201700088. Epub 2017 Dec 28.
The adult bone marrow (BM) niche is a complex entity where a homeostatic hematopoietic system is maintained through a dynamic crosstalk between different cellular and non-cellular players. Signaling mechanisms triggered by cell-cell, cell-extracellular matrix (ECM), cell-cytokine interactions, and local microenvironment parameters are involved in controlling quiescence, self-renewal, differentiation, and migration of hematopoietic stem/progenitor cells (HSPC). A promising strategy to more efficiently expand HSPC numbers and tune their properties ex vivo is to mimic the hematopoietic niche through integration of adjuvant stromal cells, soluble cues, and/or biomaterial-based approaches in HSPC culture systems. Particularly, mesenchymal stem/stromal cells (MSC), through their paracrine activity or direct contact with HSPC, are thought to be a relevant niche player, positioning HSPC-MSC co-culture as a valuable platform to support the ex vivo expansion of hematopoietic progenitors. To improve the clinical outcome of hematopoietic cell transplantation (HCT), namely when the available HSPC are present in a limited number such is the case of HSPC collected from umbilical cord blood (UCB), ex vivo expansion of HSPC is required without eliminating the long-term repopulating capacity of more primitive HSC. Here, we will focus on depicting the characteristics of co-culture systems, as well as other bioengineering approaches to improve the functionality of HSPC ex vivo.
成人骨髓(BM)龛是一个复杂的实体,其中通过不同细胞和非细胞成分之间的动态串扰维持着稳态造血系统。细胞-细胞、细胞-细胞外基质(ECM)、细胞-细胞因子相互作用以及局部微环境参数触发的信号机制参与控制造血干细胞/祖细胞(HSPC)的静止、自我更新、分化和迁移。通过将辅助基质细胞、可溶性线索和/或基于生物材料的方法整合到 HSPC 培养系统中,模拟造血龛,是一种更有效地扩增 HSPC 数量并调整其特性的有前途的策略。特别是间充质干细胞(MSC),通过其旁分泌活性或与 HSPC 的直接接触,被认为是一个相关的龛位细胞,将 HSPC-MSC 共培养定位为支持造血祖细胞体外扩增的有价值平台。为了改善造血细胞移植(HCT)的临床结果,即当可用的 HSPC 数量有限时,例如从脐带血(UCB)中收集的 HSPC,需要进行 HSPC 的体外扩增,而不会消除更原始 HSC 的长期重编程能力。在这里,我们将重点描述共培养系统的特征,以及其他生物工程方法来改善 HSPC 的体外功能。